# Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products, Division 1: General principles

Extent: E+W+S+N.I.

The purpose of the trials described in this Part is to demonstrate or to confirm the efficacy of the immunological veterinary medicinal product. All claims made by the applicant with regard to the properties, effects and use of the product, shall be fully supported by results of specific trials contained in the application for marketing authorisation.

---
Source: https://www.legislation.gov.uk/eudr/2001/82/annex/I/title/II/part/4/chapter/I/division/1 (the official version)
Page: https://openlegislation.uk/eu-directive-2001-82/annex-I/title-II/part-4/chapter-I/division-1
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.